ACTIVE

Apotheek De Belie

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result161,7 k €+38,3 %over 1 year

Gross margin466,8 k €+2,0 %over 1 year

Equity411,5 k €+14,4 %over 1 year

Workforce2,7 ETP-3,6 %over 1 year

Identity

Source · BCE/KBO

Apotheek De Belie is a Public limited company incorporated in 1982. Its registered office is in Gent. It employs on average 2,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0423.125.381
Incorporation: 06/10/1982
Legal form: Public limited company
Registered office: Lammerstraat 37
9000 Gent · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 2,7 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	466,8 k €	+2.0%	457,7 k €	+9.0%	419,9 k €	+11.1%	378,1 k €	+40.6%	268,9 k €
EBITDA	229,9 k €	+7.4%	214,1 k €	+13.3%	189 k €	-2.6%	194 k €	+69.0%	114,8 k €
Operating result	198,6 k €	+41.2%	140,7 k €	+23.9%	113,5 k €	-4.1%	118,4 k €	+198%	39,7 k €
Net result	161,7 k €	+38.3%	116,9 k €	+24.8%	93,6 k €	-9.3%	103,2 k €	+895%	-13 k €
Balance sheet
Equity	411,5 k €	+14.4%	359,8 k €	+6.5%	337,9 k €	+4.2%	324,3 k €	+7.7%	301,1 k €
Total assets	1,2 M €	+3.3%	1,1 M €	-13.2%	1,3 M €	+15.4%	1,1 M €	-12.9%	1,3 M €
Cash	182,5 k €	-8.1%	198,5 k €	+17.9%	168,4 k €	-38.1%	271,9 k €	-33.0%	405,9 k €
Debts	757,7 k €	-1.7%	770,8 k €	-20.2%	965,5 k €	+19.9%	805,5 k €	-19.1%	995,7 k €
Other
Workforce	2,7 ETP	-3.6%	2,8 ETP	+3.7%	2,7 ETP	-12.9%	3,1 ETP	-3.1%	3,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

Jan. De Belie

Director · since 06 juin 2015

Active

Pauline De Belie

Director · since 06 juin 2015

Active

BELIEPHARMA

Director · since 07 juin 2003 · 0457.655.502

Represented by Van Laere Els

Active

Ended mandates

BELIEPHARMA

Managing director · since 06 juin 2021 · until 05 juin 2027 · 0457.655.502

Represented by Els Van Laere

Ended

BELIEPHARMA

Managing director · since 06 juin 2021 · until 05 juin 2027 · 0457.655.502

Represented by Els VAN LAERE

Ended

Jan DE BELIE

Director · since 06 juin 2021 · until 05 juin 2027

Ended

Pauline De Belie

Director · since 06 juin 2021 · until 05 juin 2027

Ended

Other companies at this address

Lammerstraat 37 9000 Gent

Company	CBE no.
GANDA APOTHEKEN● Active	1040.437.440

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	25/06/2025	21/06/2024	03/07/2023	14/10/2022	30/09/2021
General meeting	24/04/2026	07/06/2025	18/05/2024	03/06/2023	04/06/2022	05/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/04/2026	30/06/2026	Dutch	PDF
Abridged model	31/12/2024	07/06/2025	25/06/2025	Dutch	PDF
Abridged model	31/12/2023	18/05/2024	21/06/2024	Dutch	PDF
Abridged model	31/12/2022	03/06/2023	03/07/2023	Dutch	PDF
Abridged model	31/12/2021	04/06/2022	14/10/2022	Dutch	PDF
Abridged model	31/12/2020	05/06/2021	30/09/2021	Dutch	PDF
Abridged model	31/12/2019	06/06/2020	02/07/2020	Dutch	PDF
Abridged model	31/12/2018	01/06/2019	03/09/2019	Dutch	PDF
Abridged model	31/12/2017	02/06/2018	23/07/2018	Dutch	PDF
Abridged model	31/12/2016	03/06/2017	19/10/2017	Dutch	PDF
Abridged model	31/12/2015	04/06/2016	30/08/2016	Dutch	PDF
Abridged model	31/12/2014	06/06/2015	31/10/2015	Dutch	PDF
Abridged model	31/12/2013	07/06/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	01/06/2013	23/07/2013	Dutch	PDF
Abridged model	31/12/2011	02/06/2012	31/07/2012	Dutch	PDF
Abridged model	31/12/2010	04/06/2011	19/08/2011	Dutch	PDF
Abridged model	31/12/2009	05/06/2010	27/07/2010	Dutch	PDF
Abridged model	31/12/2008	06/06/2009	15/10/2009	Dutch	PDF
Abridged model	31/12/2007	07/06/2008	22/07/2008	Dutch	PDF
Abridged model	31/12/2006	02/06/2007	30/11/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

Jan. De Belie

Director · since 06 juin 2015

Active

Pauline De Belie

Director · since 06 juin 2015

Active

BELIEPHARMA

Director · since 07 juin 2003 · 0457.655.502

Represented by Van Laere Els

Active

Ended mandates

BELIEPHARMA

Managing director · since 06 juin 2021 · until 05 juin 2027 · 0457.655.502

Represented by Els Van Laere

Ended

BELIEPHARMA

Managing director · since 06 juin 2021 · until 05 juin 2027 · 0457.655.502

Represented by Els VAN LAERE

Ended

Jan DE BELIE

Director · since 06 juin 2021 · until 05 juin 2027

Ended

Pauline De Belie

Director · since 06 juin 2021 · until 05 juin 2027

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Capital / shares28/07/2026
KAPITAAL - AANDELEN
PDF
Restructuring11/06/2026
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates10/01/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/07/2015
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/06/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/06/2006
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025161,7 k €↑
2024
Annual accounts 2024116,9 k €↑
2023
Annual accounts 202393,6 k €↓
2022
Annual accounts 2022103,2 k €↑
2021
Annual accounts 2021-13 k €↓
2020
Annual accounts 202078,5 k €↑
2019
Annual accounts 201938,8 k €↓
2018
Annual accounts 201865,7 k €↓
2017
Annual accounts 2017108,6 k €↑
2016
Annual accounts 201643,6 k €↑
2015
Annual accounts 201522,4 k €↓
2014
Annual accounts 201469,6 k €↑
2013
Annual accounts 201350,1 k €↓
2012
Annual accounts 201274,5 k €↑
2011
Annual accounts 201168,8 k €↓
2010
Annual accounts 201079,2 k €↑
2009
Annual accounts 200965,5 k €↓
2008
Annual accounts 2008107 k €↓
2007
Annual accounts 2007129,1 k €↑
2006
Annual accounts 200689,4 k €
06/10/1982
IncorporationPublic limited company

Apotheek De Belie

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline